Our analysis of NEUROD1 expression through TMA-based protein expression and scRNA-seq analysis is similarly revealing due to the rarity of NEUROD1-positive vs. ASCL1-positive NEPC, particularly considering the relative frequencies of NEUROD1- vs. ASCL1-positive SCLC. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.